PG-033
/ PrimeGenX Therapeutics
- LARVOL DELTA
Home
Next
Prev
1 to 2
Of
2
Go to page
1
June 03, 2026
A Phase I Clinical Trial to Evaluate the Single Dose Ascending and Food Effects of PG-033 in Healthy Adults
(clinicaltrials.gov)
- P1 | N=52 | Recruiting | Sponsor: Prime Gene Therapeutics Co., Ltd. | Trial completion date: Dec 2025 ➔ Dec 2026 | Trial primary completion date: Oct 2025 ➔ Dec 2026
Trial completion date • Trial primary completion date
June 02, 2026
A Study to Evaluate the Multiple Dose Ascending of PG-033 in Healthy Adult Participants.
(clinicaltrials.gov)
- P1 | N=30 | Not yet recruiting | Sponsor: Prime Gene Therapeutics Co., Ltd.
New P1 trial
1 to 2
Of
2
Go to page
1